The international law firm Milbank, Tweed, Hadley & McCloy LLP, led by Global Project Finance partner Dan Bartfeld, represented the Export-Import Bank of Korea (KEXIM), Sumitomo Mitsui Banking Corporation (SMBC) and Crédit Agricole Corporate & Investment Bank in the financing of the 433-MW Norte II combined cycle power plant located in Mexico’s northern state of Chihuahua. The debt to be provided to the consortium, made up of Korea Electric Power Corporation (KEPCO), Samsung C&T Corporation and Techint, S.A. de C.V., will exceed $300 million with three tranches of debt, with total project costs in excess of $400 million. The project is the largest Korean-sponsored power plant ever developed in Latin America and signifies the importance of Mexico (and Latin America) to Korean companies and KEXIM.

Shearman & Sterling is representing Quest Diagnostics Incorporated, the world’s leading provider of diagnostic testing, information and services, in its definitive agreement to acquire Celera, one of the world’s pioneers in genetic diagnostics discovery and development. The aggregate purchase price for the Celera shares is approximately $671 million, with the transaction being valued at approximately $344 million, after taking into account Celera’s $327 million in cash and short-term investments.

The Firm recently represented HCA Holdings, Inc., which is controlled by a private investor group comprised of affiliates of, or funds sponsored by, Bain Capital Partners LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners, Citigroup Inc., Bank of America Corporation and HCA founder, Dr. Thomas F. Frist, Jr., in connection with its initial public offering of common stock.  The $4.35 billion offering was the largest private-equity backed IPO ever in the United States. HCA’s common stock is now listed on the New York Stock Exchange under the ticker symbol “HCA.”

Davis Polk advised Banco de Crédito del Perú (BCP), acting through its Panamanian branch, on a Rule 144A and Regulation S offering of US$700 million aggregate principal amount of 4.75% senior notes due 2016.

Davis Polk advised Warner Chilcott plc in connection with an SEC-registered offering of 25,000,000 of its ordinary shares by certain selling shareholders for an aggregate price to the public of approximately $581 million. The selling shareholders included funds affiliated with Bain Capital Partners, J.P. Morgan Partners (advised by CCMP Capital) and Thomas H. Lee Partners, as well as members of the company’s senior management. The ordinary shares are listed on Nasdaq.

Salans advises the EPISO fund on € 300 million mega acquisition of an 80% interest in VGP’s 6 industrial parks in the Czech Republic.  It is the largest real estate investment transaction on the Czech market since 2008.

Davis Polk advised Citigroup Global Markets Inc., Wells Fargo Securities, LLC, BNP Paribas Securities Corp., RBC Capital Markets, LLC and RBS Securities Inc. as joint book-running managers on a Rule 144A/Regulation S offering of $600 million aggregate principal amount of 7.50% senior notes due 2023 by Windstream Corporation. Advice is also being provided to Citigroup Global Markets Inc. and Wells Fargo Securities, LLC as joint dealer managers of a tender offer by Windstream Corporation to purchase outstanding notes previously issued by Windstream. The tender offer will be funded in part with the proceeds of the notes offering.

Global law firm White & Case LLP has advised American Superconductor Corporation (NASDAQ: AMSC), a global power technologies company, on its €190 million acquisition of The Switch Engineering Oy, a power technologies company headquartered in Finland with substantial operations in China.

Wragge & Co’s Life Sciences team has advised biotechnology company Chroma Therapeutics Ltd on a co-development and licensing agreement with biopharmaceutical company Cell Therapeutics Inc. (CTI).